Home / Expertise / Intellectual Property
padlock hanging from turquoise painted wooden doors

Intellectual Property

China

In today’s knowledge economy, a large part of the value of your business is based on intangible assets and goodwill. Your intellectual property plays a key role in obtaining a competitive advantage. A cohesive IP strategy, including both commercialisation and enforcement, will ensure you get maximum value from your portfolio. With 150 specialist lawyers in more than 40 countries, we understand your business needs and have worked with some of the best-known brands, from banks to tech companies, pharmaceuticals and FMCG companies. This industry-specific approach can help you realise your commercial goals.

The right brands will win the hearts and minds of your customers. The right patents will prevent others exploiting your ideas or provide a substantial barrier to market access. Copyright, confidentiality and rights to designs also play a vital role. We focus on key sectors relevant to you such as lifesciences, automotive, manufacturing, consumer products, financial services and TMC. This means you get in-depth industry knowledge as well as legal expertise. If you are involved in a dispute, we can guide you through the litigation process, ensuring the best outcome in both domestic and international courts.

In China, we also have strategic collaborations with China Pharmaceutical University (CPU) and other leading academic institutions, enabling high quality technical analysis in a broad range of scientific disciplines and support from leading research professors.

Read more Read less

Feed

29/07/2021
APAC IP Up­date  – Sum­mer 2021 
China SPC re­leases ma­jor and typ­ic­al in­tel­lec­tu­al prop­erty cases for 2020 On 22 April 2021, the Su­preme People's Pro­cur­at­or­ate pub­lished the ten ma­jor in­tel­lec­tu­al prop­erty cases and 50 typ­ic­al in­tel­lec­tu­al...
20/07/2021
China makes pat­ent link­age sys­tem of­fi­cially avail­able
This month, China has is­sued three im­port­ant up­dates on the na­tion's pat­ent link­age sys­tem, which rep­res­ents a sig­ni­fic­ant step in fi­nal­ising this sys­tem, which is now of­fi­cially avail­able to phar­ma­ceut­ic­al...
13/07/2021
Open Secrets? Guard­ing value in the in­tan­gible eco­nomy
Across mul­tiple in­dus­tries, busi­nesses are de­riv­ing an ever great­er pro­por­tion of their value from as­sets pro­tec­ted not by pat­ent or copy­right – but by secrecy. And from cus­tom­er data to soft­ware al­gorithms...
29/06/2021
PRC Pro­mul­gated Data Se­cur­ity Law
The Stand­ing Com­mit­tee of the Na­tion­al People’s Con­gress on 10 June 2021 ad­op­ted the PRC Data Se­cur­ity Law (“DSL”). It will take ef­fect on 1 Septem­ber 2021. 1. Back­ground The DSL is a fun­da­ment­al...
28/06/2021
PRC Pro­mul­gated Data Se­cur­ity Law
The Stand­ing Com­mit­tee of the Na­tion­al People’s Con­gress on 10 June 2021 ad­op­ted the PRC Data Se­cur­ity Law (“DSL”). It will take ef­fect on 1 Septem­ber 2021. 1. Back­ground The DSL is a fun­da­ment­al...
14/06/2021
EPO ap­proach to ex­amin­ing com­puter im­ple­men­ted in­ven­tions
On Tues­day 25 May 2021, Heli Pih­la­jamaa, dir­ect­or of pat­ent law at the European Pat­ent Of­fice, gave a present­a­tion to CIPA’s com­puter tech­no­logy com­mit­tee on the Pat­entab­il­ity of com­puter-im­ple­men­ted...
08/06/2021
Trade secrets in China
Gen­er­al 1. Has the Dir­ect­ive (EU) 2016/943 of the European Par­lia­ment and of the Coun­cil of 8 June 2016 on the pro­tec­tion of un­dis­closed know-how and busi­ness in­form­a­tion (trade secrets) against their...
Comparable
01/06/2021
APAC IP Up­date  – Spring 2021 
China SPP is­sues guid­ing cases tar­get­ing in­tel­lec­tu­al prop­erty-re­lated crimes On 4 Feb­ru­ary 2021, the Su­preme People's Pro­cur­at­or­ate (SPP) is­sued the 26th Batch of Guid­ing Cases tar­get­ing in­tel­lec­tu­al...
01/06/2021
Some leaks can­'t be fixed
“Con­fid­en­tial in­form­a­tion is like an ice cube... give it to the party who has no re­fri­ger­at­or or will not agree to keep it in one, and by the time of the tri­al you have just a pool of wa­ter.” This...
21/05/2021
China’s Pat­ent Link­age Sys­tem - Pat­ent in­form­a­tion re­gis­tra­tion plat­form...
On 18 May 2021, China’s Centre for Drug Eval­u­ation (CDE) is­sued a No­tice on the Pub­lic Test­ing of the Early Res­ol­u­tion Mech­an­ism of Drug Pat­ent Dis­pute Re­lated Pat­ent In­form­a­tion Re­gis­tra­tion Plat­form...
06/05/2021
High­lights on New Reg­u­la­tions on Su­per­vi­sion and Ad­min­is­tra­tion of Med­ic­al...
On 18 March 2021, the State Coun­cil pro­mul­gated the Reg­u­la­tions on Su­per­vi­sion and Ad­min­is­tra­tion of Med­ic­al Devices (Re­vised in 2021), which will take ef­fect on 1 June 2021 (the "New Med­ic­al Device Reg­u­la­tions")...
16/04/2021
CMS, China Nom­in­ated in ALB China Law Awards 2021
We are pleased to an­nounce that CMS, China has been nom­in­ated again as “IP Law Firm of the Year – In­ter­na­tion­al” and “Real Es­tate Law Firm of the Year – In­ter­na­tion­al” in ALB (Asi­an Leg­al...